Mental-health conditions, specialty meds driving drug plan cost increases in 2019: report
Private drug plans saw the largest yearly increase in their average eligible costs in 2019, according to Telus Health’s annual drug trends report. The report attributed the rise to a jump in the use and cost of specialty drugs and a growth in younger Canadians using medication for mental-health challenges. It also noted the repeal of the OHIP+ program […]
- July 9, 2020 November 12, 2020
- 10:00